■ 学術雑誌
|
原著
|
|
1.
|
中西 健太郎, 吉岡 弘鎮, 奥野 祐希子, 上硲 敬介, 竹安 優貴, 勝島 詩恵, 山中 雄太, 中村 聡明, 畑地 治, 倉田 宝保：
長期生存時代において脳転移を有する再発非小細胞肺癌の定位放射線治療による晩期障害として放射線脳壊死を来した1例.
肺癌
65
(2)
：113
-119
, 2025
|
|
2.
|
池田慧、清家正博、小澤雄一、花田満美、長谷川一男、川崎由華、伊藤ゆり、池田徳彦：
患者・医師アンケート2023から見えてくる、肺がん治療と仕事の両立支援のいま.
肺癌
65
(2)
：80
-90
, 2025
|
|
3.
|
Felip E, Rojas CI, Schenker M, Kowalski DM, Casarini IA, Csöszi T, Şendur
MAN, Martins J, Blanco AC, Wang CC, Song X, Ramirez Fallas RAL, Yoshioka H, Nair
S, Wang M, Deng X, Lala M, Eiras R, Takahashi T.：
Subcutaneous Versus Intravenous Pembrolizumab, in Combination With Chemotherapy, for Treatment of Metastatic Non-Small Cell Lung Cancer: The Phase 3 3475A-D77 Trial.
Annals of oncology
36
(7)
：775
-785
, 2025
|
|
4.
|
Aosa Sasada, Hayato Kawachi, Tadaaki Yamada, Tae Hata, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Asuka Okada, Yusuke Chihara, Takashi Kijima, Koichi Takayama：
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression.
Anticancer research
45
(11)
：5045
-5057
, 2025
|
|
5.
|
Takashi Nojiri, Akiisa Omura, Kiyotsugu Iede, Utae Katsushima, Masahiko Higashiyama：
Clinical Impact of Upfront Dose Reduction of the First Cycle of First-Line Treatments on Safety and Survival in Elderly Patients With Non-Small Cell Lung Cancer.
Asia-Pacific journal of clinical oncology
：Online ahead of print
, 2025
|
|
6.
|
Utae Katsushima, Takuya Fukushima, Jiro Nakano, Kazuki Fujii, Yutaro Nagata, Keisuke Kamisako, Yukiko Okuno, Kiyori Yoshida, Tatsuki Ikoma, Yuki Takeyasu, Yuta Yamanaka, Hiroshige Yoshioka, Takayasu Kurata, Eisuke Ochi：
Combined effects of slow movement training with tonic force generation and aerobic exercise prior to cancer therapy in patients with lung cancer (START-lung): a pilot feasibility trial.
BMC cancer
25
(1)
：1438
, 2025
|
|
7.
|
Nishioka N, Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N,
Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata
D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T,
Takayama K.：
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study.
Cancer research and treatment
57
(2)
：412
-421
, 2025
|
|
8.
|
Tae Hata, Tadaaki Yamada, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Yusuke Chihara, Hayato Kawachi, Takashi Kijima, Koichi Takayama：
Chemoimmunotherapy outcomes and prognostic factors in patients with advanced, low PD-L1-expressing non-small cell lung cancer.
Cancer research communications
5
(7)
：1203
-1214
, 2025
|
|
9.
|
Hidenobu Ishii, Koichi Azuma, Fumiaki Kiyomi, Kohei Yoshimine, Kazuki Uchida, Kazunori Tobino, Tadaaki Yamada, Tsutomu Iwasa, Hiroaki Kanemura, Toshiyuki Sumi, Eiji Iwama, Masataka Mori, Masaru Takenaka, Yuki Takeyasu, Takayasu Kurata, Shunsuke Misono, Kentaro Tanaka, Isamu Okamoto：
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study).
Cancer treatment and research communications
45
：101008
, 2025
|
|
10.
|
Kanda S, Niho S, Kurata T, Nomura S, Kawashima Y, Iwama E, Yokoyama T,
Watanabe Y, Tanaka H, Fujiwara Y, Zenke Y, Azuma K, Taniguchi H, Toyozawa R,
Hosomi Y, Murakami H, Hara S, Bessho A, Yamamoto N, Ohe Y.：
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-doublet Chemotherapy for Non-small Cell Lung Cancer Harboring EGFR Mutation.
Clinical cancer research
31
(12)
：2317
-2326
, 2025
|
|
11.
|
Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma
T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K,
Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K.：
Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.
Clinical lung cancer
26
(3)
：e190
-e198.e4
, 2025
|
|
12.
|
Tae Hata, Tadaaki Yamada, Naoki Furuya, Hisashi Tanaka, Akihiro Yoshimura, Tomohiro Oba, Makoto Hibino, Takahito Fukuda, Yasuhiro Goto, Akira Nakao, Shinsuke Ogusu, Yuta Okazaki, Taishi Harada, Takayo Ota, Ken Masubuchi, Koji Mikami, Shoki Matsumoto, Ryoichi Honda, Koji Date, Yusuke Chihara, Hayato Kawachi, Kenji Morimoto, Koichi Takayama：
Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations.
Clinical lung cancer
26
(8)
：e639
-e648
, 2025
|
|
13.
|
Shunichi Kataoka, Takehito Shukuya, Hiroshi Ohtsu, Taichi Miyawaki, Daichi Fujimoto, Hidetoshi Hayashi, Yukihiro Toi, Toshihide Yokoyama, Teruhumi Kato, Teppei Yamaguchi, Kaoru Tanaka, Satoru Miura, Motohiro Tamiya, Motoko Tachihara, Kohei Otsubo, Yuki Sato, Satoshi Ikeda, Shinya Sakata, Takeshi Masuda, Shinnosuke Takemoto, Nobuyuki Yamamoto, Isamu Okamoto, Kazuhisa Takahashi,：
Multicenter real-world data on first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer and performance status 2: WJOG18424L.
Clinical lung cancer
, 2025
|
|
14.
|
Shogen Boku, Tatsuki Ikoma, Tomoyo Yasuda, Nobuhiro Shibata, Tomofumi Sakagami, Kensuke Suzuki, Takuo Fujisawa, Hiroshi Iwai, Masashi Kanai：
Relationship between the effectiveness of pembrolizumab monotherapy and ABO blood type in recurrent and metastatic squamous cell carcinoma of the head and neck.
Discover oncology
16
(1)
：1302
, 2025
|
|
15.
|
Y Shiraishi, T Shimose, Y Tsuchiya-Kawano, H Ishii, K Mizuno, Y Toi, H Daga, K Ito, S Iyama, H Taniguchi, R Morinaga, T Harada, H Inoue, Y Misumi, K Naoki, K Tobino, M Izumi, S Omori, S Tsumura, Y Yamanaka, Y Sakata, S Miura, H Mizutani, M Oki, E Iwama, K Otsubo, I Okamoto：
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED).
ESMO open
10
(7)
：105325
, 2025
|
|
16.
|
A Yoshimura, T Takeda, K Tanimura, Y Chihara, H Kawachi, Y Yamanaka, N Tamiya, R Honda, T Yamada, K Uryu, S Shiotsu, H Yoshioka, T Yamada, T Kurata, K Takayama：
Impact of the Lung Immune Prognostic Index in non-small-cell lung cancer patients with PD-L1-low/negative tumors receiving chemoimmunotherapy: a real-world multicenter retrospective study.
ESMO open
：Online ahead of print
, 2025
|
|
17.
|
Graham L Cohen, Corlia Coetzee, Cathryn A Walton, Òscar Reig Torras, Byoung Chul Cho, Georgina McAdam, Carlos I Rojas, Laura Medina Rodríguez, Zsuzsanna Papai, Sze W Chan, Bernardo L Rapoport, Christian Caglevic, Patricio Yañez Weber, Toshiaki Takahashi, Takayasu Kurata, Gina Song, Julia W Cohen, Omobolaji O Akala, Richard Khanyile：
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18.
European journal of cancer (Oxford, England : 1990)
230
：115709
, 2025
|
|
18.
|
Gina Song, Mustafa Erman, Gastón Lucas Martinengo, Judit Kocsis, Gopal Kunta, Mengzhao Wang, Hiroshige Yoshioka, Carolina de Miranda Silva, Mallika Lala：
Model-based dose selection and pharmacokinetic bridging of subcutaneous from intravenous pembrolizumab across indications.
European journal of cancer (Oxford, England : 1990)
230
：115711
, 2025
|
|
19.
|
Norifumi Tsubokawa, Yasuhiro Tsutani, Tomoyuki Hishida, Hisashi Saji, Masashi Wakabayashi, Makoto Endo, Takahiro Mimae, Tomohiro Miyoshi, Tetsuya Isaka, Mitsuhiro Isaka, Aritoshi Hattori, Hiroshige Yoshioka, Ryu Nakajima, Masaya Yotsukura, Tomohiro Maniwa, Yuta Sekino, Haruhiko Fukuda, Kazuo Nakagawa, Keiju Aokage, Shun-Ichi Watanabe, Morihito Okada：
Quality comparison of mediastinal lymph node dissection between video-assisted thoracic surgery and open thoracotomy: a supplementary analysis of the phase 3 Japan Clinical Oncology Group 1413 trial.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
67
(7)
：ezaf206
, 2025
|
|
20.
|
Shogen Boku, Tomoyo Yasuda, Tatsuki Ikoma, Eri Matsumori, Sawako Yoshiuchi, Yoshiyuki Matsuo, Koichiro Higasa, Takayasu Kurata：
Anamorelin in Cancer Cachexia: Gut Microbiota Effects and CONUT Score as a Predictor of Response.
In vivo (Athens, Greece)
39
(6)
：3626
-3635
, 2025
|
|
21.
|
Kenji Morimoto, Tadaaki Yamada, Naoki Furuya, Hisashi Tanaka, Akihiro Yoshimura, Tomohiro Oba, Makoto Hibino, Takahito Fukuda, Yasuhiro Goto, Akira Nakao, Shinsuke Ogusu, Yuta Okazaki, Taishi Harada, Takayo Ota, Ken Masubuchi, Koji Mikami, Tae Hata, Shoki Matsumoto, Ryoichi Honda, Koji Date, Yusuke Chihara, Koichi Takayama：
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study.
International journal of clinical oncology
30
(10)
：1963
-1971
, 2025
|
|
22.
|
Ishida Y, Ikeda S, Harada T, Sakakibara-Konishi J, Yokoo K, Kikuchi H, Iwasawa T, Misumi T, Konno S, Ogura T.：
High incidence of immune checkpoint inhibitor-induced pneumonitis in patients with non-small cell lung cancer and interstitial pneumonia, regardless of honeycomb lung or forced vital capacity: results from a multicenter retrospective study.
International journal of clinical oncology
30
(5)
：904
-913
, 2025
|
|
23.
|
Yasuhiro Mihashi, Kiyohide Komuta, Akihiro Tsukaguchi, Reiko Inada, Atsushi Yanagisawa, Yuhei Shimizu, Ken Yamamoto, Satoshi Tanaka, Naoko Katsurada, Takeshi Nakatani, Yuki Takeyasu, Taiichiro Otsuki, Satoshi Tetsumoto, Akihiro Tamiya, Takayuki Shiroyama, Motoko Tachihara, Kazumi Nishino, Takayasu Kurata, Masahide Mori：
Multicenter retrospective study of selpercatinib treatment for advanced or recurrent RET fusion-positive non-small cell lung cancer in Japan.
Investigational new drugs
：Online ahead of print
, 2025
|
|
24.
|
Hidenobu Ishii, Koichi Azuma, Yuta Yamanaka, Hiroshige Yoshioka, Yukihiro Toi, Naoki Shingu, Katsuhiko Naoki, Masaki Okamoto, Yuko Tsuchiya-Kawano, Taishi Harada, Hiroyuki Inoue, Hiroshi Ishii, Kazunori Tobino, Chiho Nakashima, Yoshifusa Koreeda, Yasushi Hisamatsu, Shinsuke Tsumura, Takashi Inagaki, Keiko Mizuno, Takayuki Shimose, Isamu Okamoto：
Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003).
JTO clinical and research reports
6
(7)
：100836
, 2025
|
|
25.
|
Katsushima U, Kurose S, Fukushima T, Nakano J, Ogushi N, Fujii K, Nagata Y,
Kamisako K, Okuno Y, Okazaki Y, Nakanishi K, Yoshida K, Ikoma T, Takeyasu Y,
Yamanaka Y, Yoshioka H, Hase K, Kurata T.：
Impact of time to treatment initiation on the development of cachexia and clinical outcomes in lung cancer.
Japanese journal of clinical oncology
55
(5)
：505
-513
, 2025
|
|
26.
|
Sato Y, Tani Y, Ishii H, Katakura S, Oki M, Watanabe Y, Yokoyama T, Naoki K, Pouliot JF, Kaul M, Paccaly A, Visich JE, Kim E, Mani J, Li Y, Lowy I, Seebach F, Mathias M, Ikeda S.：
Cemiplimab in Japanese patients with advanced non-small cell lung cancer.
Japanese journal of clinical oncology
：Online ahead of print
, 2025
|
|
27.
|
Miura S, Tanaka H, Misumi T, Yoshioka H, Tokito T, Fukuhara T, Sato Y,
Shiraishi Y, Naoki K, Akamatsu H, Yamaguchi O, Yokoyama T, Kuyama S, Nishino K,
Furuya N, Kurata T, Kato T, Ikeda S, Horinouchi H, Ichihara E, Mori M, Takiguchi
Y, Tanaka K, Goto Y, Okamoto H; Thoracic Oncology Research Group and all
ACHILLES investigators.：
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.
Journal of clinical oncology
43
(18)
：2049
-2058
, 2025
|
|
28.
|
Fukui T, Mamesaya N, Takahashi T, Kishi K, Yoshizawa T, Tokito T, Azuma K,
Morikawa K, Igawa S, Okuma Y, Yamanaka Y, Hosokawa S, Kasai T, Masubuchi K,
Nakamichi S, Aga M, Sasaki J, Kada A, Saito AM, Naoki K, Okamoto H; Thoracic
Oncology Research Group (TORG).：
A Prospective Phase II Trial of First-line Osimertinib for Patients with EGFR Mutation-positive Non-small Cell Lung Cancer and Poor Performance Status (OPEN/TORG2040).
Journal of thoracic oncology
20
(5)
：665
-675
, 2025
|
|
29.
|
Akamatsu H, Sakata S, Azuma K, Yoshioka H, Uemura T, Tsuchiya-Kawano Y, Esumi
S, Kurosaki T, Sato Y, Sakamoto T, Ninomiya K, Toyozawa R, Yoneshima Y, Shukuya
T, Kozuki T, Watanabe K, Daga H, Kato T, Takahashi T, Osuga M, Koh Y, Morita S,
Yamamoto N.：
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET).
Journal of thoracic oncology
20
(6)
：775
-785
, 2025
|
|
30.
|
Ikeda S, Ogura T, Miyaoka E, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Seike M, Takahashi K, Yamamoto N, Yotsukura M, Watanabe S, Shintani Y.：
Survival Benefit and Potential Markers of Chemotherapy for Elderly and Poor Performance Status Patients with Advanced Non-Small Cell Lung Cancer: Results from the Japanese Joint Committee of Lung Cancer Registry Database.
Lung Cancer
200
：108102
, 2025
|
|
31.
|
Tachihara M, Shoda H, Akazawa Y, Ota T, Oki M, Sato Y, Sugawara S, Ikeda S, Yokoyama T, Kaneda H, Itoh S, Bessho A, Katakami N, Morita S, Nakagawa K, Okamoto I, Yamamoto N.：
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase II study (WJOG13520L).
Lung Cancer
206
：108637
, 2025
|
|
32.
|
Byoung Chul Cho, Hidetoshi Hayashi, Jong-Seok Lee, Se-Hoon Lee, Pongwut Danchaivijitr, Ying Cheng, Baogang Liu, Adlinda Alip, Hailin Xiong, Soon Hin How, Gee-Chen Chang, James Chih-Hsin Yang, Hiroshige Yoshioka, Mehmet Ali Nahit Şendur, Kumar Prabhash, Koichi Azuma, Yun-Gyoo Lee, Chien-Chung Lin, Shingo Matsumoto, Patrapim Sunpaweravong, Yichuan Xia, Melissa Martinez, Joshua M Bauml, Seema Sethi, Shun Lu：
Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset.
Lung cancer (Amsterdam, Netherlands)
204
：108496
, 2025
|
|
33.
|
Shogo Nomura, Yuta Sekino, Yoshimasa Shiraishi, Yukihiro Toi, Tatsuya Yoshida, Kentaro Tanaka, Shinichiro Suzuki, Koichi Azuma, Satoshi Hara, Ryo Morita, Seiji Niho, Takuyuki Koda, Ryo Toyozawa, Kiyotaka Yoh, Takayasu Kurata, Haruhiko Fukuda, Yuichiro Ohe, Isamu Okamoto：
A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands)
204
：108584
, 2025
|
|
34.
|
Junichi Soh, Hiromasa Yamamoto, Norihito Okumura, Hiroyuki Suzuki, Masao Nakata, Toshiya Fujiwara, Kenicehi Gemba, Isao Sano, Takuji Fujinaga, Masafumi Kataoka, Yasuhiro Terasaki, Nobukazu Fujimoto, Kazuhiko Kataoka, Shinji Kosaka, Motohiro Yamashita, Hidetoshi Inokawa, Masaaki Inoue, Hiroshige Nakamura, Yoshinori Yamashita, Yuta Takahashi, Hidejiro Torigoe, Hiroki Sato, Shuta Tomida, Katsuyuki Hotta, Hiroshige Yoshioka, Satoshi Morita, Keitaro Matsuo, Junichi Sakamoto, Hiroshi Date, Shinichi Toyooka：
Association of the expression of 5-FU biomarkers with aging and prognosis in elderly patients with lung cancer treated with S-1 adjuvant chemotherapy: Follow-up results of the Setouchi Lung Cancer Group Study 1201.
Molecular and clinical oncology
23
(3)
：79
, 2025
|
|
35.
|
Tomohito Saito, Mitsuaki Ishida, Tomoya O Akama, Shiho Hattori, Natsumi Maru, Takahiro Utsumi, Aki K Kobayashi, Kento J Fukumoto, Hiroshi Matsui, Yohei Taniguchi, Yoshinobu Hirose, Katsuyasu Kouda, Tomohiro Murakawa：
Clinical and pathological implications of the presence of MECA-79-expressing tumor cells in pathological stage IA lung adenocarcinoma.
PloS one
20
(10)
：e0323233
, 2025
|
|
36.
|
Nishimura M, Sekine A, Inafuku K, Moriuchi A, Tagami Y, Ikeda S, Oda T, Misumi T, Arai H, Baba T, Komatsu S, Hagiwara E, Iwasawa T, Kaneko T, Ogura T.：
Incidence and risk factors of unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after lung cancer surgery in interstitial lung disease patients. Respir Investig.
Respir Investig
63
(5)
：983
-990
, 2025
|
|
37.
|
Kenji Morimoto, Tadaaki Yamada, Naoki Furuya, Hisashi Tanaka, Akihiro Yoshimura, Tomohiro Oba, Makoto Hibino, Takahito Fukuda, Yasuhiro Goto, Akira Nakao, Shinsuke Ogusu, Yuta Okazaki, Taishi Harada, Takayo Ota, Ken Masubuchi, Koji Mikami, Tae Hata, Shoki Matsumoto, Ryoichi Honda, Koji Date, Yusuke Chihara, Hayato Kawachi, Koichi Takayama：
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure.
Targeted oncology
20
(3)
：531
-541
, 2025
|
|
38.
|
James Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi, Enriqueta Felip, Alexander I Spira, Nicolas Girard, Yu Jung Kim, Se-Hoon Lee, Yurii Ostapenko, Pongwut Danchaivijitr, Baogang Liu, Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Benjamin Besse, Antonio Passaro, Ki-Hyeong Lee, Hailin Xiong, Soon-Hin How, Ying Cheng, Gee-Chen Chang, Hiroshige Yoshioka, Michael Thomas, Danny Nguyen, Sai-Hong Ignatius Ou, Sanjay Mukhedkar, Kumar Prabhash, Manolo D'Arcangelo, Jorge Alatorre-Alexander, Juan Carlos Vázquez Limón, Sara Alves, Daniil Stroyakovskiy, Marina Peregudova, Mehmet Ali Nahit Şendur, Ozan Yazici, Raffaele Califano, Vanesa Gutiérrez Calderón, Filippo de Marinis, Sang-We Kim, Shirish M Gadgeel, Scott Owen, John Xie, Tao Sun, Jaydeep Mehta, Raja Venkatasubramanian, Mariah Ennis, Elizabeth Fennema, Mahesh Daksh, Amy Roshak, Julie Man, Roland E Knoblauch, Joshua M Bauml, Mahadi Baig, Sujay Shah, Seema Sethi, Byoung Chul Cho,：
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.
The New England journal of medicine
393
(17)
：1681
-1693
, 2025
|
|
39.
|
Masashi Ishihara, Takahisa Kawamura, Yukiko Namba, Yuki Takeyasu, Yukihiro Hasegawa, Yuki Sato, Yoshiki Negi, Tomohiro Oba, Toshiyuki Sumi, Hirokuni Hirata, Hidemitsu Funabashi, Yuko Oya, Hajime Kikuchi, Naoko Katsurada, Takeshi Nakatani, Keiko Tanimura, Taku Nakagawa, Naoya Takeda, Takahiro Asami, Osamu Honjo, Hiromi Nagashima, Takumi Yamaura, Norihiko Hata, Miyako Kitazono, Naoya Nishioka, Akihiro Tamiya, Yuichi Sakamori, Ryota Shigaki, Kyoichi Kaira, Ryoichi Honda, Takashi Matsui, Eriko Suzuki, Kentaro Ito, Kojiro Otsuka, Naoto Takase, Yusuke Murakami, Kazuhiko Matsuno, Sumito Inoue, Akira Kisohara, Sojiro Kusumoto, Hiroe Aoshima, Yumiko Kakizaki, Akihito Kubo, Akito Hata, Nobuhisa Ishikawa, Kosuke Hamai, Nobuhiro Kanaji, Toshihiro Misumi, Noriyuki Matsutani, Nobuhiko Seki：
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).
Therapeutic advances in medical oncology
17
：17588359251344010
, 2025
|
|
40.
|
Shiho Goda, Tadaaki Yamada, Kenji Morimoto, Tae Hata, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Asuka Okada, Makoto Hibino, Yusuke Chihara, Takashi Kijima, Koichi Takayama：
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.
Translational lung cancer research
14
(4)
：1185
-1196
, 2025
|
|
41.
|
Hayato Kawachi, Tae Hata, Tadaaki Yamada, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Yusuke Chihara, Takashi Kijima, Koichi Takayama：
Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression.
Translational lung cancer research
14
(5)
：1558
-1568
, 2025
|
|
総説及び解説
|
|
1.
|
藤本 一志，池田 慧：
【あらためて考える—肺癌周術期治療 課題とこれから】Ⅵ. ドライバー遺伝子変異/転座を有する非小細胞肺癌の周術期治療 EGFR遺伝子変異陽性非小細胞肺癌に対する周術期治療.
呼吸器ジャーナル
73
(1)
：101
-110
, 2025
|
|
2.
|
池田慧、立石和也、田中健介：
高度に専門化する肺がん診療にどんと構えるために チーム医療、共同意思決定、薬の選び方.
内科
153
(2)
：303
-310
, 2025
|
|
